Maria Fardis

EVP, Operations and Alliances, Pharmacyclics.

Companies

Obsidian Therapeutics, Inc.Board member Aug 3, 2026 to now¹
CRISPR TherapeuticsBoard member Jun 10, 2022 to now²
Iovance BiotherapeuticsBoard member Jun 9, 2016 to Jan 6, 2021³
Iovance BiotherapeuticsChief executive officer Jun 9, 2016 to Jan 6, 2021³
Iovance BiotherapeuticsPresident Jun 9, 2016 to Jan 6, 2021³
PharmacyclicsEVP, Operations and Alliances Sep 27, 2012 to Nov 17, 2014⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARObsidian Therapeutics, Inc., Board member
2
SEC EDGARCRISPR Therapeutics, Board member
3
SEC EDGARIovance Biotherapeutics, Board member
4
SEC EDGARPharmacyclics, EVP, Operations and Alliances